Helius Medical Technologies, Inc. Announces Publication of Peer-Reviewed Study: Translingual Neural ...Sep 08, 2020Helius Medical Technologies, Inc. Announces FDA Has Granted the PoNS Device Breakthrough Device Desi...May 12, 2020
In the News
Oct 15, 2020
As Seen On ...
PoNS™ is an authorized medical device and commercially available in Canada. PoNS™ is an investigational device in the US, EU, and Australia and is currently under review for market clearance by the AUS TGA; PoNS™ is not commercially available in the US, EU, or Australia.
The device is intended for use as a short term treatment (14 weeks) of chronic balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with physical therapy. The device is intended for use as a short term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from MS and is to be used in conjunction with physical therapy.